 |
Technical Support
(877) SEPAX-US, press 3  TechSupport@sepax-tech.com |
  |
Search Results
Product
| Proteomix HIC Butyl - View more details | Sign In to see pricing, or order online |
| Part Number | Phase | Particle Size | Pore Size | ID×Length | Buy or Quote |
|---|---|---|---|---|---|
| 431NP5-4603 | Proteomix HIC Butyl | 5 µm | Non-Porous | 4.6×35mm | |
Application
| ADC/MAb Separation on Proteomix HIC - View application note |
| Literature Reference: Novel Thienoduocarmycin-trastuzumab ADC Demonstrates Strong Anti-tumor Efficacy - View application note |
| MAb/ADC Fragment Separation after IDeS Digestion - View application note |
| Intact MAb, ADC and their Fragments Analysis on RP LC/MS - View application note |
| MAb hydrophobicity screening on Proteomix HIC Butyl-NP5 - View application note |
| Erbitux and Rituximab Monoclonal Antibody Separation on Proteomix HIC Butyl NP5 - View application note |
| Intact and Oxidized Monoclonal Antibody Separation on Proteomix HIC - View application note |
| Intact and Oxidized MAb Analysis on Proteomix HIC Butyl 1.7 µm - View application note |
| HICP1001 - Fusion protein Analysis on Proteomix® HICBu-NP5 ( 4603 ) - View application note |
| Literature Reference: Design and Characterization of Homogenous Antibody-drug Conjugates with a Drug-to-Antibody Ratio of One Prepared Using an Engineered Antibody and a Dual-maleimide Pyrrolobenzodiazepine Dimer - View application note |